« Back
Home /
Recombinant Human Thrombopoietin

Recombinant Human Thrombopoietin

Manufacturer	Cell Sciences
Category	Oncology By Cell Type Hematology Leukemia Peptides & Proteins Recombinant Proteins Cell Biology Cell Culture Cytokines Myelofibrosis By Organ Heart & Blood Cancer
Type	Proteins
Specific against	Human
Amount	10 ug
Host	E.coli
Item no.	CS-CRT400B
Targets	CD110, THPO
eClass 6.1	34160400
eClass 9.0	42020190
Available
Biological Activity	Determined by the dose-dependant stimulation of MO7e cells. The ED50 is less than 1 ng/ml.
Description	Recombinant Human THPO is a single, non-glycosylated polypeptide chain containing 174 amino acids and having a MW of 18.6 kDa, which comprises the receptor binding domain of the Mpl-ligand protein.
Endotoxin Level	Less than 0.1 ng/ug of THPO
Formulation	Sterile filtered, lyophilized from a concentrated (1 mg/ml) solution in water containing no additives.
Reconstitution	Centrifuge vial prior to opening . Reconstitute in sterile water not less than 100 ug/ml, which can then be diluted further to other aqueous solutions.
Storage and Stability	Lyophilized THPO although stable at room temperature for 3 weeks, should be stored desiccated below -20C. Upon reconstitution, recombinant THPO should be stored at, 2-4C between 2-7 days and for future use below -20C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze-thaw cycles .
Specificity	1 x 106 IU/mg

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.